1 week Ago By ABMN Staff
Norges Bank bought a new stake in Core Laboratories Inc. ( NYSE:CLB – Free Report ) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 110,328 shares of the oil and gas company’s stock, valued at approximately $1,910,000.
Several other hedge funds have also bought and sold shares of the stock. Raymond James Financial Inc. purchased a new position in shares of Core Laboratories during the 4th quarter valued at about $6,760,000.
Rice Hall James & Associates LLC purchased a new position in shares of Core Laboratories during the fourth quarter worth approximately $1,960,000. JPMorgan Chase & Co. raised its stake in shares of Core Laboratories by 161.
7% during the fourth quarter. JPMorgan Chase & Co. now owns 108,028 shares of the oil and gas company’s stock worth $1,870,000 after acquiring an additional 66,747 shares in the last quarter.
Barclays PLC lifted its holdings in shares of Core Laboratories by 288.2% in the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after acquiring an additional 62,042 shares during the last quarter.
Finally, State Street Corp boosted its stake in shares of Core Laboratories by 2.9% in the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock valued at $36,597,000 after purchasing an additional 56,187 shares in the last quarter.
97.81% of the stock is currently owned by institutional investors. Core Laboratories Stock Performance NYSE:CLB opened at $12.
13 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.
71 and a current ratio of 2.32. Core Laboratories Inc.
has a fifty-two week low of $10.14 and a fifty-two week high of $25.13.
The firm has a market cap of $566.54 million, a PE ratio of 18.38, a price-to-earnings-growth ratio of 0.
99 and a beta of 1.99. The business has a 50 day moving average price of $15.
02 and a 200-day moving average price of $17.65. Core Laboratories Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd.
Shareholders of record on Monday, February 10th were issued a $0.01 dividend. This represents a $0.
04 annualized dividend and a yield of 0.33%. The ex-dividend date was Monday, February 10th.
Core Laboratories’s dividend payout ratio (DPR) is currently 6.06%. Wall Street Analysts Forecast Growth Separately, Citigroup upgraded shares of Core Laboratories from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $15.
00 to $16.00 in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock.
According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $17.50. Read Our Latest Stock Report on CLB Core Laboratories Company Profile ( Free Report ) Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally.
It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. See Also Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Core Laboratories Inc. ( NYSE:CLB – Free Report ). Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.
com's FREE daily email newsletter ..
